Clinical trials
Completed trials in Japan with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
365 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 10 |
| 2006 | 8 |
| 2007 | 17 |
| 2008 | 18 |
| 2009 | 23 |
| 2010 | 17 |
| 2011 | 22 |
| 2012 | 28 |
| 2013 | 31 |
| 2014 | 19 |
| 2015 | 23 |
| 2016 | 26 |
| 2017 | 33 |
| 2018 | 14 |
| 2019 | 19 |
| 2020 | 8 |
| 2021 | 12 |
| 2022 | 5 |
| 2023 | 10 |
| 2024 | 3 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 365 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hiroshima University | 19 |
| Boston Scientific Corporation | 13 |
| Alcon Research | 12 |
| Showa Inan General Hospital | 12 |
| Kyorin University | 11 |
| Abbott Medical Devices | 10 |
| Medtronic Cardiac Rhythm and Heart Failure | 9 |
| Kyoto University, Graduate School of Medicine | 7 |
| Philip Morris Products S.A. | 7 |
| Tokyo University | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 22 |
| Cardiovascular Diseases | 12 |
| Cataract | 9 |
| Heart Failure | 9 |
| Peripheral Arterial Disease | 9 |
| Atrial Fibrillation | 8 |
| Myocardial Ischemia | 8 |
| Atherosclerosis | 7 |
| Coronary Disease | 7 |
| Ischemic Stroke | 7 |
Trials
Showing 1 to 25 of 365. Each trial links to its page on Pharma Observatory.
265 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.